Skip to main content
logo
Maravai LifeSciences Holdings, Inc. (MRVI)
NASDAQ: MRVI · Real-Time Price · USD
3.340
-0.070 (-2.05%)
At close: Oct 27, 2025, 4:00 PM EDT
3.400
+0.060 (1.80%)
After-hours: Oct 27, 2025, 5:56 PM EDT

MRVI Revenue by Segment

Period EndingJun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020
Nucleic Acid Production
151.68M179.08M196.35M213.27M214.55M209.33M224.77M355.23M
Nucleic Acid Production Growth
-29.30%-14.45%-12.65%-39.96%-55.20%-67.84%-72.36%-57.52%
Biologics Safety Testing
64.32M62.93M62.99M63.65M64.03M64.77M64.18M64.29M
Biologics Safety Testing Growth
0.45%-2.84%-1.85%-0.99%-1.53%-3.13%-8.23%-8.74%
Protein Detection
---------------25.44M26.24M23.31M22.88M

Adjusted EBITDA by Segment

Period EndingJun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020
Biologics Safety Testing
44.00M42.59M43.84M45.90M46.22M47.09M46.91M46.52M
Biologics Safety Testing Growth
-4.80%-9.56%-6.54%-1.33%-4.25%-9.54%-14.47%-16.77%
Nucleic Acid Production
3.25M31.83M50.81M70.85M71.98M64.87M82.66M194.09M
Nucleic Acid Production Growth
-95.48%-50.94%-38.53%-63.50%-76.88%-86.58%-87.05%-70.88%

Revenue by Geography

Period EndingJun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020
North America
121.31M122.99M127.09M132.08M131.91M133.92M141.06M174.99M
North America Growth
-8.03%-8.16%-9.90%-24.52%-44.62%-54.30%-58.45%-50.34%
APAC
63.54M78.80M89.38M93.60M95.30M89.21M97.44M113.10M
APAC Growth
-33.33%-11.67%-8.27%-17.24%-4.65%-24.38%-11.25%19.34%
EMEA
30.42M39.57M42.06M50.53M50.69M50.30M49.92M130.78M
EMEA Growth
-40.00%-21.33%-15.76%-61.36%-75.27%-83.56%-88.47%-71.50%
Latin and Central America
586.00K501.00K662.00K706.00K686.00K681.00K527.00K649.00K
Latin and Central America Growth
-14.58%-26.43%25.62%8.78%-14.04%-19.60%-34.78%-5.67%
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.